Received: 13 May 2022
Accepted: 16 August 2022
First Online: 25 August 2022
: The studies involving human participants were reviewed and approved by the Clinical Research Ethics Committee of the Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University (approval number: 2018KY032–01). Written informed consents were obtained from the patients or their legally authorized representatives. All patient data were de-identified.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.